Thermo Fisher Raises $1.5B Debt To Fund Patheon Acquisition
Thermo Fisher Scientific Inc. said Friday it priced a two-part, $1.5 billion debt offering to help fund its acquisition of Dutch pharmaceutical contract development and manufacturing company Patheon NV, three days...To view the full article, register now.
Already a subscriber? Click here to view full article